Covid: UK get early access to 60 million doses of vaccine

The UK government after reaching an agreement with GlaxoSmithKline and Sanofi Pasteur has secured early access to 60 million doses Covid vaccine for 2021.

The UK government has set early access to 60 million doses of Covid vaccine. It comes after signing a deal with GlaxoSmithKline and Sanofi Pasteur. If this vaccine candidate is accepted, the UK would get the vaccine and use it in the first half of 2021.

UK government signed a deal for 60 million doses of Covid vaccine

The vaccine human trial should start in September and continue to Phase 3 study in December 2020.

Thus, the UK government secured early access to four different types of immunisation and a total of 250 million doses. However the parts haven’t already published the financial terms of the agreement.

Business Secretary Alok Sharma commented: “Our scientists and researchers are racing to find a safe and effective vaccine at a speed and scale never seen before. While this progress is truly remarkable, the fact remains that there are no guarantees.

It is important that we secure early access to a diverse range of promising vaccine candidates, like GSK and Sanofi. To increase our chances of finding one that works so we can protect the public and save lives.”

Kate Bingham, chair of the government’s vaccines taskforce, added: “Through this agreement, we can add another type of vaccine to the three different types of vaccine we have already secured. This diversity of vaccine types is important because we do not yet know which, if any, of the different types of vaccine will prove to generate a safe and protective response to Covid. Whilst this agreement is very good news, we mustn’t be complacent or over optimistic.”

In line with Boris Johnson’s warning that there are signs of a second wave sweeping Europe. UK may implemeted quarantine for arrivals from Luxembourg and Belgium tomorrow. The ministers are still keeping an eye on Croatia.